ADAR1 Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.41M	Buy	227,717 +201,223	+760%	+$6.47M	0.45%	56
2025 Q4	$932K	Sell	26,494 -149,425	-85%	-$5.29M	0.07%	137
2025 Q3	$4.62M	Buy	175,919 +108,106	+159%	+$3.23M	0.46%	51
2025 Q2	$1.8M	Buy	67,813 +8,400	+14%	+$221K	0.29%	58
2025 Q1	$1.43M	Buy	59,413 +50,113	+539%	+$1.58M	0.28%	67
2024 Q4	$374K	Buy	9,300 +2,200	+31%	+$125K	0.08%	123
2024 Q3	$450K	Sell	7,100 -84,127	-92%	-$4.94M	0.08%	121
2024 Q2	$4.84M	Buy	91,227 +76,826	+533%	+$5.04M	0.97%	21
2024 Q1	$1.18M	Sell	14,401 -239,750	-94%	-$10.7M	0.32%	56
2023 Q4	$4.73M	Buy	+254,151	New	+$3.32M	2.12%	14